CARDIOVASCULAR ENDOCRINOLOGY: Tailoring antihypertensive drug treatment to body size

    loading  Checking for direct PDF access through Ovid


A study in patients with hypertension suggests that thiazide diuretic treatment provides less cardiovascular protection in patients of normal weight than in those with obesity, whereas a calcium channel blocker is equally effective across BMI categories. Does this finding mean that body size should be the driving force in the choice of antihypertensive drug treatment?

Related Topics

    loading  Loading Related Articles